Zydus Lifesciences Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 4,236 | 2,757.40 | 3,412.70 |
| Operating Expense | 1,858.60 | 2,144.70 | 1,719.30 |
| Net Profit | 1,722 | 296.50 | 1,156.60 |
| Net Profit Margin | 40.65% | 10.75% | 33.89% |
| Earning Per Share | 17.11 | 2.95 | 11.49 |
| EBIDTA | 2,435.10 | 638.60 | 1,688.10 |
| Effective Tax Rate | 18.79% | 13.35% | 16.64% |
Particulars
Mar 2026
Revenue4,236
Operating Expense1,858.60
Net Profit1,722
Net Profit Margin40.65
Earning Per Share17.11
EBIDTA2,435.10
Effective Tax Rate18.79
